Andrew P. Han
Andrew Han covers breaking news for GenomeWeb. He tracks companies in the sequencing and diagnostic markets.

Articles Authored by Andrew P. Han
Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes
Premium
Memorial Sloan Kettering Cancer Center is among the first healthcare systems to implement the rapid sequencing assay, which can consolidate single-gene tests.
UK NHS Declines to Accelerate Grail Galleri Implementation Following Early Data Review
The decision comes just weeks after Grail officials touted the decision as a potential positive catalyst for the firm as it prepares to be divested by Illumina.
European Commission Approves Illumina's Plan for Divesting Grail
Whether Illumina will sell Grail to another firm or pursue a capital markets transaction such as an initial public offering is yet to be determined.
German Children's Cancer Center Aims to Expand Global Access to Methylation-Based Tumor Classifier
Premium
The program will provide funding and expertise to clinics in low-income countries to run methylation array-based assays to classify central nervous system tumors in children.
Phase Genomics Lands $2.5M in Grants to Develop Diagnostic Score For Genomic Aberrations in Cancer
The grants include a two-year $2 million SBIR award from the National Cancer Institute and a $500,000 grant from Washington's Andy Hill Care Fund.
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.
UMiami Researchers to Study Cell Therapy Response in Lymphoma Using WGS, Single-Cell RNA-seq
Premium
The team has received a $1.5 million US Department of Defense grant to help launch its project on diffuse B-cell lymphoma resistance to CAR T-cell therapy.
Thermo Fisher Scientific's IonTorrent Genexus platform can provide cancer panel results in about a day, but data on clinical impact of the fast turnaround has not yet been produced.
Natera Eyes Regulatory Path for Signatera as Companion Diagnostic
The firm isn't planning a strategy for a kitted version of the test, though company officials said they were open to that in the future.
Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
Premium
The firm is also bringing its comprehensive genomic profiling assay for cancer to the Ion Torrent Genexus sequencing platform in the first half of 2023.